Wellington Management Group LLP Exelixis, Inc. Transaction History

Wellington Management Group LLP

$545 Billion
Q3 2025

A detailed history of Wellington Management Group LLP transactions in Exelixis, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 88,170 shares of EXEL stock, worth $3.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,170

Previous 98,980 10.92%

Holding current value

$3.67 Million

Previous $4.36 Million 16.55%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$36.22 - $46.25 $391,538 - $499,962	-10,810 Reduced 10.92%	88,170 $3.64 Million
Q2 2025 Aug 14, 2025	SELL	$34.13 - $46.26 $1.68 Million - $2.28 Million	-49,218 Reduced 33.21%	98,980 $4.36 Million
Q1 2025 May 13, 2025	BUY	$32.38 - $39.16 $4.8 Million - $5.8 Million	148,198 New	148,198 $5.47 Million
Q4 2024 Feb 12, 2025	SELL	$25.39 - $36.46 $2.72 Million - $3.9 Million	-106,934 Reduced 43.59%	138,408 $4.61 Million
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $2.73 Million - $3.44 Million	-124,537 Reduced 33.67%	245,342 $6.37 Million

Q2 2024 Aug 13, 2024	BUY	$20.34 - $23.73 $1.54 Million - $1.8 Million	75,941 Added 25.84%	369,879 $8.31 Million
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $5.93 Million - $7.03 Million	293,938 New	293,938 $6.98 Million
Q4 2023 Feb 12, 2024	BUY	$19.25 - $24.13 $2.5 Million - $3.14 Million	129,935 New	129,935 $3.12 Million
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $75,227 - $89,845	-3,951 Reduced 3.66%	103,886 $2.27 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $364,344 - $410,664	20,052 Added 22.84%	107,837 $2.06 Million
Q1 2023 May 12, 2023	BUY	$16.3 - $19.41 $290,025 - $345,362	17,793 Added 25.42%	87,785 $1.7 Million
Q4 2022 Feb 13, 2023	BUY	$14.96 - $17.39 $624,714 - $726,189	41,759 Added 147.91%	69,992 $1.12 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $442,693 - $628,748	28,233 New	28,233 $442,000
Q4 2021 Feb 11, 2022	SELL	$15.84 - $21.88 $375,756 - $519,037	-23,722 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $386,668 - $501,483	23,722 New	23,722 $502,000
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $2.28 Million - $3.08 Million	-124,120 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.67 - $26.94 $2.57 Million - $3.34 Million	124,120 New	124,120 $3.04 Million
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $743,186 - $1.12 Million	-51,396 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$15.15 - $18.89 $778,649 - $970,870	51,396 New	51,396 $906,000

Others Institutions Holding EXEL

# of Institutions

693

Shares Held

257M

Call Options Held

1.5M

Put Options Held

1.71M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $13.4B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Exelixis, Inc. Transaction History